The National Institutes of Health (NIH) posted the following on their ‘Clinical Trials’ website.
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
It appears this is a two part placebo-controlled study to determine dosage and potential safety issues as well as the any change in thigh muscle volume. The trial is to begin this month.
I will post more information as it becomes available.
No comments:
Post a Comment
Please feel free to comment. By taking a moment to share your thoughts you add much to these articles. The articles then become more than just something I said or believe. In addition, by adding a comment, you might just be helping the next reader by sharing your opinion, experience, or a helpful tip. You can comment below or by sending me an email. I look forward to hearing from you.